QUALITY: Development of a novel patient-specific quality assurance device for Heavy Ion Therapy (HIT)

• Forschungsstelle: INNOSUISSE
• Projektnummer: 109.136 INT-LS
• Projekttitel Englisch: QUALITY: Development of a novel patient-specific quality assurance device for Heavy Ion Therapy (HIT)

Schlüsselwörter (Englisch)

Life sciences, Medtech, Medical diagnostics

Abstract (Englisch)

The goal of the project is to deliver a dedicated, patient-specific quality assurance system for heavy ion therapy. The final product, Qualyscan®II, is the world?s first medical device for non-invasive 3D-tomographic dosimetry during heavy ion cancer therapy, based on secondary gamma ray detection.